Jorge Kirilovsky
GlaxoSmithKline (France)(FR)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Protein Degradation and Inhibitors, RNA Interference and Gene Delivery, Pharmacological Effects and Assays, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Suppression of inflammation by a synthetic histone mimic(2010)1,563 cited
- → Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains(2011)334 cited
- → The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1‘,2‘:1,6]pyrido[3,4-b]indole-1,4-dione Analogues(2003)279 cited
- → Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)(2012)207 cited
- → The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione Analogues(2003)192 cited
- → From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151(2012)118 cited
- → Using Advanced Intercross Lines for High-Resolution Mapping of HDL Cholesterol Quantitative Trait Loci(2003)92 cited
- → Delipidation of a beta-adrenergic receptor preparation and reconstitution by specific lipids.(1983)76 cited
- → Effects of C‐type natriuretic peptide on rat cardiac contractility(1999)61 cited
- → Acetylcholine receptor expression in primary cultures of embryonic chick myotubes—II. Comparison between the effects of spinal cord cells and calcitonin gene-related peptide(1989)28 cited